CGEN
Compugen Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.47
+0.41%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.07
- Revenue estimate
- $1.3M
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.08
- Revenue actual
- $2.6M
- Revenue estimate
- $1.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12.3%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.08 | -$0.07 | Beat 12.52% | $2.6M |
| May 18, 2026 | -$0.07 | -$0.08 | Miss -14.29% | $2.2M |
| Aug 6, 2025 | -$0.07 | -$0.08 | Miss -14.29% | $1.3M |
| May 19, 2025 | -$0.06 | -$0.08 | Miss -33.33% | $2.3M |
| Mar 4, 2025 | $0.07 | -$0.07 | Miss -200.00% | $1.5M |
| May 20, 2024 | -$0.10 | -$0.08 | Beat 20.00% | $2.6M |
| Mar 5, 2024 | $0.23 | $0.11 | Miss -52.17% | $33.5M |
| May 15, 2023 | -$0.12 | -$0.11 | Beat 8.33% | — |
| Feb 27, 2023 | -$0.14 | -$0.04 | Beat 71.43% | $7.5M |
| Nov 14, 2022 | -$0.13 | -$0.14 | Miss -7.69% | — |
| Aug 4, 2022 | -$0.12 | -$0.11 | Beat 8.33% | — |
| May 16, 2022 | -$0.12 | -$0.11 | Beat 8.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026